UBS AM’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Buy
130,503
+9,423
+8% +$75.1K ﹤0.01% 2284
2025
Q4
$730K Sell
121,080
-22,858
-16% -$136K ﹤0.01% 2239
2025
Q3
$822K Sell
143,938
-150,445
-51% -$769K ﹤0.01% 2070
2025
Q2
$1.48M Buy
294,383
+95,320
+48% +$511K ﹤0.01% 2275
2025
Q1
$1.29M Buy
199,063
+17,738
+10% +$158K ﹤0.01% 2200
2024
Q4
$1.33M Buy
181,325
+40,954
+29% +$323K ﹤0.01% 2234
2024
Q3
$1.05M Sell
140,371
-30,188
-18% -$262K ﹤0.01% 2369
2024
Q2
$1.52M Buy
170,559
+78,500
+85% +$753K ﹤0.01% 2143
2024
Q1
$933K Hold
92,059
﹤0.01% 2049
2023
Q4
$926K Buy
92,059
+11,645
+14% +$106K ﹤0.01% 2064
2023
Q3
$753K Sell
80,414
-8,829
-10% -$126K ﹤0.01% 2113
2023
Q2
$2.08M Hold
89,243
﹤0.01% 1626
2023
Q1
$2.08M Buy
89,243
+17,498
+24% +$448K ﹤0.01% 1626
2022
Q4
$1.82M Buy
71,745
+8,514
+13% +$209K ﹤0.01% 1568
2022
Q3
$1.22M Sell
63,231
-15,335
-20% -$390K ﹤0.01% 1854
2022
Q2
$2M Buy
78,566
+11,086
+16% +$259K ﹤0.01% 1612
2022
Q1
$1.74M Buy
67,480
+2,438
+4% +$72.3K ﹤0.01% 1863
2021
Q4
$2.72M Buy
65,042
+1,323
+2% +$51.8K ﹤0.01% 1724
2021
Q3
$2.77M Buy
63,719
+549
+0.9% +$23.8K ﹤0.01% 1684
2021
Q2
$2.99M Buy
63,170
+53,111
+528% +$2.41M ﹤0.01% 1664
2021
Q1
$516K Hold
10,059
﹤0.01% 2376
2020
Q4
$269K Sell
10,059
-118,199
-92% -$3.84M ﹤0.01% 2434
2020
Q3
$4.4M Sell
128,258
-21,599
-14% -$930K ﹤0.01% 1207
2020
Q2
$6.14M Buy
+149,857
New +$5.03M ﹤0.01% 1045

Other funds holding VIR